Literature DB >> 3014387

Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease.

A M Palmer, A W Procter, G C Stratmann, D M Bowen.   

Abstract

Brains of normal controls and patients with primary degenerative dementia were investigated for choline acetyltransferase (ChAT) activity in the frontal, temporal and parietal cortex, hippocampus, amygdala and thalamus. A few patients with Alzheimer's disease were unusual as the cholinergic marker was unaffected, except in the amygdala. Other patients with dementia and undiagnosed neurodegenerative disorder had elevated cortical ChAT activity. The interpretations offered are: (a) the syndrome of dementia and Alzheimer pathologic change precedes significant loss of cortical cholinergic innervation; (b) denervation in dementia can occur early in olfactory areas, exemplified here by the amygdala; (c) dementia is associated with the loss of non-cholinergic structure. An indication of structures involved was given by loss of a marker of excitatory amino acid-releasing neurones.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014387     DOI: 10.1016/0304-3940(86)90190-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

2.  In vivo characterization of the early states of the amyloid-beta network.

Authors:  Jorge Sepulcre; Mert R Sabuncu; Alex Becker; Reisa Sperling; Keith A Johnson
Journal:  Brain       Date:  2013-07       Impact factor: 13.501

Review 3.  Hippocampal plasticity during the progression of Alzheimer's disease.

Authors:  E J Mufson; L Mahady; D Waters; S E Counts; S E Perez; S T DeKosky; S D Ginsberg; M D Ikonomovic; S W Scheff; L I Binder
Journal:  Neuroscience       Date:  2015-03-12       Impact factor: 3.590

4.  A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease.

Authors:  M M Esiri; R C Pearson; J E Steele; D M Bowen; T P Powell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

5.  The dementia of Alzheimer's disease: an update.

Authors:  P T Francis; R Carl; A Pearson; S L Lowe; J W Neal; P H Stephens; T P Powell; D M Bowen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

Review 6.  The cholinergic hypothesis of Alzheimer's disease: a review of progress.

Authors:  P T Francis; A M Palmer; M Snape; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

7.  Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type.

Authors:  A Najlerahim; D M Bowen
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

8.  Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain.

Authors:  T Storck; S Schulte; K Hofmann; W Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 9.  Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.

Authors:  Dapinder Kaur; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Simona Bungau
Journal:  Neurochem Res       Date:  2021-08-06       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.